This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Evolving Strategies in the Diagnosis and Management of Autosomal Dominant Polycystic Kidney Disease

Evolving Strategies in the Diagnosis and Management of Autosomal Dominant Polycystic Kidney Disease

Format

Monograph

Time to Complete

1.50 hours

Released

March 21, 2018

Expires

March 21, 2019
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 Credit(s)TM
1.50 / CE for Nurses

Accredited Provider

This activity is jointly provided by Medical Education Resources and CMEology.

Commercial Supporter

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Program Description

Hear from Dr. Arlene Chapman, Professor of Medicine at the University of Chicago and one of the leading experts in autosomal dominant polycystic kidney disease (ADPKD), in this multimedia text article which features videos with expert commentary and animated slides with narration. A case study approach is used to illustrate the latest advancements in the diagnosis and treatment of this rare disease, as well as prediction of disease progression, clinical manifestations, and management. Two clinical tools will be available for download. The first tool is a questionnaire designed to assist in screening and testing for ADPKD. The second tool is a handout with helpful information for the newly diagnosed patient.

Intended Audience

The activity has been designed to meet the educational needs of nephrologists, nephrology nurse practitioners, and other health care providers caring for patients with ADPKD.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Identify ADPKD early, including recognition of patients through screening and family history
  • Describe the cellular and molecular pathogenesis of ADPKD and how it informs potential treatment targets
  • Apply strategies for risk prediction and monitoring of ADPKD progression

Conflict Of Interest Disclosure Policy

Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Faculty and Disclosures

Arlene Chapman, MD
Professor of Medicine
Director, Section of Nephrology
Department of Medicine
Director, Clinical Research Center
Institute for Translational Medicine
Biological Sciences Division
University of Chicago
Chicago, IL

Dr. Chapman discloses the following:
Grants/Research Support: CP30, NIDDK, Kansas PI
Consulting Fees: Otsuka America Pharmaceutical, Inc.

Accredited Provider Disclosure

Barb Hansen, PharmD, has no financial relationships to disclose

Publishing Staff Disclosures

Rob Lowney, CMEology, has no financial relationships to disclose.
Dana Ravyn, PhD, MPH, CMEology, has no financial relationships to disclose.
Beth Goodwin, CMEology, has no financial relationships to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and CMEology. MER is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Medical Education Resources designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.50

Type

CE for Nurses

Accreditation Statement

Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This CE activity provides 1.50 contact hours of continuing nursing education. Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.50 contact hours.

Disclosure of Unlabeled Use

This CME/CE activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. MER and CMEology do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of MER or CMEology.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources and/or CMEology. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, providers should consult primary references and full prescribing information. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. You will have 3 tries to obtain a passing score. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue